Concepedia

Ali R. Jazirehi

AR

Statistics

Publications

36

Citations

2.5K

H-Index

27

Active since

2001

Affiliations

University of California, Los Angeles(Current)

Laboratory of Molecular Genetics

Centro Médico Nacional La Raza

University of Colorado Denver

Pomona College

Ali R. Jazirehi is an author at University of California, Los Angeles specializing in oncology, medicine, and pharmacology.

Publications per year

2001–2018

36

Publications

36

Inhibition of the Raf–MEK1/2–ERK1/2 Signaling Pathway, Bcl-xL Down-Regulation, and Chemosensitization of Non-Hodgkin’s Lymphoma B Cells by Rituximab

Ali R. Jazirehi, Mario I. Vega, Devasis Chatterjee et al. · Cancer Research · 2004 · 188 citations

, , +17

Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.

Ali R. Jazirehi, Sara Huerta‐Yépez, Genhong Cheng et al. · PubMed · 2005 · 178 citations

, , +17

Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression

Sara Huerta‐Yépez, Mario I. Vega, Ali R. Jazirehi et al. · Oncogene · 2004 · 164 citations

, , +17

Development of Rituximab-Resistant Lymphoma Clones with Altered Cell Signaling and Cross-Resistance to Chemotherapy

Ali R. Jazirehi, Mario I. Vega, Benjamin Bonavida · Cancer Research · 2007 · 162 citations · Full text

, , +17

Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) Inhibits the Constitutive Nuclear Factor-κB Signaling Pathway in Non-Hodgkin's Lymphoma B-Cell Lines: Role in Sensitization to Chemotherapeutic Drug-induced Apoptosis

Ali R. Jazirehi, Sara Huerta‐Yépez, Genhong Cheng et al. · Cancer Research · 2005 · 144 citations · Full text

, , +17

1–5 of 36